PMV Pharmaceuticals adopts amended bylaws effective June 8, 2023

PMV Pharmaceuticals, Inc.

Amended and Restated Bylaws approved by Board on April 24, 2023, effective at 2023 annual meeting.
Updates advance notice procedures for director nominations, including Rule 14a-19 compliance evidence requirement.
Revises provisions on stockholder meetings, board action by written consent, and director/committee matters to conform to Delaware law.
Also updates various provisions to conform to recent amendments to DGCL and makes ministerial clarifications.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

PMV Pharmaceuticals, Inc.: Amended and restated bylaws to update advance notice procedures, conform to DGCL amendments, and make ministerial changes (effective 2023-06-08).

Change: bylaw amendment
Effective: 2023-06-08

Exact text from the filing

to be effective on June 8, 2023, the date of the Company’s 2023 annual meeting of stockholders.

View on SEC.gov

51 governance changes filed in the last 30 days. Browse all governance changes →

PMV Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-23-124381

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.